Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.

Despite all the years doctors in the U.S. and Canada spend studying and training, very little time is typically dedicated to treating pain.

For chronic pain patients, though, the brain interprets even neutral sensations as pain and suffering. In effect, pain ...

Scientists have discovered a brain circuit that gives pain its emotional sting, explaining why some hurts linger as suffering ...

Treatment with HCCP led to significant improvements in pain, sleep quality, mood, and overall quality of life in patients with PNI.

Scientists at the Salk Institute have uncovered how a cluster of thalamic neurons links physical pain to emotional trauma, ...

Lower back pain is the most common diagnosis seen by physical therapists. Most cases will resolve in less than two weeks with ...

Scientists have discovered novel drug candidates which could ultimately lead to new effective treatments for conditions ...

A large U.S. medical records study has found that adults prescribed gabapentin six or more times for chronic low back pain face significantly higher risks of dementia (29%) and mild cognitive ...

Platelet-rich plasma therapy provided significant, durable relief of chronic noncancer pain, outperforming both corticosteroid and hyaluronic acid injections.

Pain isn't just a physical sensation-it also carries emotional weight. That distress, anguish, and anxiety can turn a ...

Learn how CBD might help nerve pain. Healthline's team has selected the best CBD products of 2025 for you.